A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma: KCSG HN18-07

被引：0
|
作者：
An, Hojung
Keam, Bhumsuk
Shin, Seong Hoon
Kim, Min Kyoung
Kim, Sung-Bae
机构：
[1] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Kosin Univ, Gospel Hosp, Busan, South Korea
[4] Yeungnam Univ Univ Hosp, Daegu, South Korea
[5] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6020
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: A prospective phase II trial
    Zhang, Wen
    Li, Yong
    Xue, Liyan
    Qu, Dong
    Jiang, Zhichao
    Gao, Shugeng
    Zhou, Aiping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] A randomized phase II of radiation and continuous infusion of 5FU+docetaxel or docetaxel plus cisplatin in the treatment of locally advanced pancreatic carcinoma. Interim analysis of the accord 9 trial
    Viret, Frederic
    Ychou, Marc
    Cobat, Aurelie
    Bennouna, Jaafar
    Conroy, Thierry
    Adenis, Antoine
    Gamelin, E.
    Abbas, M.
    Montoto-Grillot, Christine
    Ducreux, Michel
    ANNALS OF ONCOLOGY, 2006, 17 : 322 - 322
  • [43] Phase I/II trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) followed by concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    Satake, Hironaga
    Tahara, Makoto
    Mochizuki, Satoshi
    Zenda, Sadamoto
    Kojima, Takashi
    Bando, Hideaki
    Yamazaki, Tomoko
    Kato, Ken
    Iwasa, Satoru
    Honma, Yoshitaka
    Hara, Hiroki
    Yokota, Tomoya
    Hamauchi, Satoshi
    Kiyota, Naomi
    Kii, Takayuki
    Chin, Keisho
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma
    Susumu Nakahara
    Yukinori Takenaka
    Kazuhiko Ogawa
    Suetaka Nishiike
    Yoshifumi Yamamoto
    Yuji Seo
    Fumiaki Isohashi
    Osamu Suzuki
    Yasuo Yoshioka
    Iori Sumida
    Tadashi Yoshii
    Yoichiro Tomiyama
    Hidenori Inohara
    International Journal of Clinical Oncology, 2016, 21 : 1030 - 1037
  • [45] A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Koh, Youngil
    Lee, Keun-Wook
    Kim, Sung-Bae
    Park, Kyong Hwa
    Shin, Sang Won
    Kang, Jin Hyoung
    Keam, Bhumsuk
    Lee, Se-Hoon
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma
    Nakahara, Susumu
    Takenaka, Yukinori
    Ogawa, Kazuhiko
    Nishiike, Suetaka
    Yamamoto, Yoshifumi
    Seo, Yuji
    Isohashi, Fumiaki
    Suzuki, Osamu
    Yoshioka, Yasuo
    Sumida, Iori
    Yoshii, Tadashi
    Tomiyama, Yoichiro
    Inohara, Hidenori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (06) : 1030 - 1037
  • [47] A phase II study of weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC).
    Yun, Fan
    Zhou, Xinming
    Jiang, Youhua
    Chen, Qixun
    Huang, Zhiyu
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [48] Neoadjuvant therapy with local advanced oral cavity carcinoma:: Induction chemotherapy with docetaxel/cisplatin/5-FU followed by simultaneous radiation therapy plus docetaxel/cisplatin followed by OP, phase-I-study:: Current evaluation of the compatibility and effectiveness
    Grehl, S.
    Eberhardt, W.
    Poettgen, C.
    Jawad, Abu J.
    Kaelberlah, H. P.
    Wierlemann, A.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 83 - 84
  • [49] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
  • [50] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
12345